Rising prevalence of genetic disorders across the globe and growing need for fast and accurate diagnosis are some key factors driving the global market revenue growth.
Rising prevalence of genetic disorders across the globe and growing need for fast and accurate diagnosis are some key factors driving the global market revenue growth
Market Dynamics:
Revenue growth of the global Sanger sequencing services market is primarily attributed to factors such as rising prevalence of genetic diseases across the globe, growing need for rapid and accurate disease diagnosis, increasing awareness of the benefits of the Sanger sequencing method, and rising demand for Sanger sequencing services among pharmaceutical and biotechnology companies. Sanger sequencing, also known as the ‘chain termination method,’ refers to the process of determining the nucleotide sequence of the DNA (deoxyribonucleic acid).
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/789
Discovered in the year 1977 by two-time Nobel Laureate Frederick Sanger and his collaborators, Sanger sequencing is a cost-effective method for sequencing of single genes, and the method involves the analysis of short tandem repeats (STRs). Significant progress and breakthroughs in the fields of genomics and proteomics, latest advances in sequencing data analytics, growing application of the Sanger sequencing method in clinical diagnosis for variant discovery, and rising focus on development of more advanced and effective drugs for genetic diseases are other key factors expected to fuel revenue growth of the market over the forecast period.
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Biomarkers & Cancer Segment Accounted for Largest Revenue Share in 2020:
The biomarkers & cancer segment dominated other segments in terms of revenue share in the global market in 2020. Rising burden of different types of cancer, continuous advancements in the field of cancer research, rising demand for effective cancer diagnostics and therapeutics, and increasing use of the Sanger sequencing method in discovery of novel cancer biomarkers are key factors supporting revenue growth of this segment.
Pharmaceutical & Biotechnology Companies Segment to Account for Fastest Revenue CAGR:
The pharmaceutical & biotechnology companies segment is expected to register the fastest revenue growth rate in the global market over the forecast period. Rapid adoption of the Sanger sequencing method by pharmaceutical and biotechnology companies for identification of genetic variations, rising prevalence of cancer and genetic diseases worldwide, and increasing government investments in pharmaceutical and biotechnological research & development projects are among the major factors expected to drive revenue growth of this segment.
Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/789
North America Accounted for Largest Revenue Share in 2020:
Among regional markets, the North America Sanger sequencing services market accounted for largest revenue share in the global market in 2020. Major factors driving revenue growth of this regional market are rising prevalence of cancer and various genetic disorders, increasing government and private investments in cancer and genomic research initiatives, technological advancements in the Sanger sequencing process, and presence of leading market players in the region, such as Thermo Fisher Scientific, Quintara Biosciences, and GenHunter Corporation.
Major Companies in the Global Sanger Sequencing Services Market Include:
- Source BioScience
- GenScript Biotech Corporation
- Thermo Fisher Scientific
- LGC Science Group Limited
- Fasteris SA
- CeMIA SA
- Quintara Biosciences
- GenHunter Corporation
- GENEWIZ
- Nucleics
- SciGenom Labs Pvt. Ltd.
- Microsynth AG. Inc.
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/sanger-sequencing-services-market
For the purpose of this report, Emergen Research has segmented the global Sanger sequencing services market based on application, end-use, and region:
Application Outlook (Revenue, USD Billion; 2018-2028)
- Diagnostics
- Biomarkers & Cancer
- Reproductive Health
- Personalized Medicine
- Forensics
- Others
End-use Outlook (Revenue, USD Billion; 2018-2028)
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
- Academic & Research Institutes
Region Outlook (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Insights into our Other Published Healthcare Reports:
Cardiac Monitoring & Cardiac Rhythm Management Devices Market To Be Worth USD 29.32 Billion by 2027 | Emergen Research
Neurostimulation Devices Market To Reach USD 13.70 Billion by 2027 Growing at a CAGR of 12.6% | Emergen Research
Industrial Microbiology Market To Be Worth USD 17.71 Billion by 2027| Emergen Research
Surgical Instrument Tracking Systems Market To Reach USD 431.6 Million by 2027| Emergen Research
Medical Lighting Technologies Market Size To Be Worth USD 2.99 Billion by 2027 | Emergen Research
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services